Your browser doesn't support javascript.
loading
Molecular diagnostics in the era of COVID-19.
Jayakody, Harindi; Kiddle, Guy; Perera, Semali; Tisi, Laurence; Leese, Hannah S.
Afiliação
  • Jayakody H; Materials for Health Lab, Department of Chemical Engineering, University of Bath, Bath, UK. h.s.leese@bath.ac.uk.
  • Kiddle G; Erba Molecular, Ely, Cambridgeshire, UK. l.tisi@erbamannheim.com.
  • Perera S; Erba Molecular, Ely, Cambridgeshire, UK. l.tisi@erbamannheim.com.
  • Tisi L; Materials for Health Lab, Department of Chemical Engineering, University of Bath, Bath, UK. h.s.leese@bath.ac.uk.
  • Leese HS; Erba Molecular, Ely, Cambridgeshire, UK. l.tisi@erbamannheim.com.
Anal Methods ; 13(34): 3744-3763, 2021 09 02.
Article em En | MEDLINE | ID: mdl-34473144
ABSTRACT
As the COVID-19 pandemic continues to escalate globally and acquires new mutations, accurate diagnostic technologies continue to play a vital role in controlling and understanding the epidemiology of this disease. A plethora of technologies have enabled the diagnosis of individuals, informed clinical management, aided population-wide screening to determine transmission rates and identified cases within the wider community and high-risk settings. This review explores the application of molecular diagnostics technologies in controlling the spread of COVID-19, and the key factors that affect the sensitivity and specificity of the tests used.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article